Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MBX Biosciences (MBX) Gains from Investment Securities (2023 - 2026)

MBX Biosciences has reported Gains from Investment Securities over the past 4 years, most recently at $11.4 million for Q1 2026.

  • Quarterly results put Gains from Investment Securities at $11.4 million for Q1 2026, up 42262.96% from a year ago — trailing twelve months through Mar 2026 was $15.2 million (up 1115.95% YoY), and the annual figure for FY2025 was $4.6 million, up 2314.57%.
  • Gains from Investment Securities reached $11.4 million in Q1 2026 per MBX's latest filing, up from $2.8 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $11.4 million in Q1 2026 and bottomed at $27000.0 in Q1 2025.
  • Median Gains from Investment Securities over the past 4 years was $200348.0 (2024), compared with a mean of $2.0 million.
  • The largest annual shift saw Gains from Investment Securities crashed 82.91% in 2025 before it soared 42262.96% in 2026.
  • Over 4 years, Gains from Investment Securities stood at $140000.0 in 2023, then surged by 515.0% to $861000.0 in 2024, then soared by 230.89% to $2.8 million in 2025, then surged by 301.47% to $11.4 million in 2026.
  • Business Quant data shows Gains from Investment Securities for MBX at $11.4 million in Q1 2026, $2.8 million in Q4 2025, and $193519.0 in Q3 2025.